ES2148178T3 - Uso de derivados de sulfamato como inhibidores de esteroide-sulfatasa. - Google Patents

Uso de derivados de sulfamato como inhibidores de esteroide-sulfatasa.

Info

Publication number
ES2148178T3
ES2148178T3 ES92918285T ES92918285T ES2148178T3 ES 2148178 T3 ES2148178 T3 ES 2148178T3 ES 92918285 T ES92918285 T ES 92918285T ES 92918285 T ES92918285 T ES 92918285T ES 2148178 T3 ES2148178 T3 ES 2148178T3
Authority
ES
Spain
Prior art keywords
steroid
sulfatase inhibitors
inhibitors
estrogeno
sulfamato
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92918285T
Other languages
English (en)
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterix Ltd
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ES2148178T3 publication Critical patent/ES2148178T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Surgical Instruments (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE PRESENTAN NUEVOS INHIBIDORES DE SULFATASA ESTEROIDAL ASI COMO COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN PARA SU USO EN EL TRATAMIENTO DE TUMORES ESTROGENO DEPENDIENTES, ESPECIALMENTE CANCER DE PECHO. LOS NUEVOS INHIBIDORES DE SULFATASA ESTEROIDAL SON ESTERES DE SULFAMATO DE FORMULA (I), DONDE R1 Y R2 CADA UNO ES H, ALQUILO, CICLOALQUILO O ARILO, O JUNTOS REPRESENTAN UN GRUPO ALQUILENO QUE CONTIENE OPCIONALMENTE UN HETEROATOMO, POR EJEMPLO -O SIDUO DE UN ALCOHOL POLICICLICO, PREFERENTEMENTE UN ESTEROL, MAS PREFERENTEMENTE UN 3-ESTEROL. LOS COMPUESTOS PREFERIDOS SON ESTROGENO-3-SULFAMATO Y N,N-DIMETIL ESTROGENO-3-SULFAMATO.
ES92918285T 1991-08-29 1992-08-28 Uso de derivados de sulfamato como inhibidores de esteroide-sulfatasa. Expired - Lifetime ES2148178T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919118478A GB9118478D0 (en) 1991-08-29 1991-08-29 Steroid sulphatase inhibitors

Publications (1)

Publication Number Publication Date
ES2148178T3 true ES2148178T3 (es) 2000-10-16

Family

ID=10700604

Family Applications (4)

Application Number Title Priority Date Filing Date
ES98204340T Expired - Lifetime ES2196483T3 (es) 1991-08-29 1992-08-28 Inhibidores de la sulfatasa esteroidea.
ES98204337T Expired - Lifetime ES2193475T3 (es) 1991-08-29 1992-08-28 Composiciones farmaceuticas que contienen derivados de sulfamato como inhibidores de la sulfatasa esteroidea.
ES99203449T Expired - Lifetime ES2204059T3 (es) 1991-08-29 1992-08-28 Utilizacion de un compuesto de esterol que comprende un grupo ester del acido sulfamico para la preparacion de medicamentos para el control de la produccion de estrogenos.
ES92918285T Expired - Lifetime ES2148178T3 (es) 1991-08-29 1992-08-28 Uso de derivados de sulfamato como inhibidores de esteroide-sulfatasa.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES98204340T Expired - Lifetime ES2196483T3 (es) 1991-08-29 1992-08-28 Inhibidores de la sulfatasa esteroidea.
ES98204337T Expired - Lifetime ES2193475T3 (es) 1991-08-29 1992-08-28 Composiciones farmaceuticas que contienen derivados de sulfamato como inhibidores de la sulfatasa esteroidea.
ES99203449T Expired - Lifetime ES2204059T3 (es) 1991-08-29 1992-08-28 Utilizacion de un compuesto de esterol que comprende un grupo ester del acido sulfamico para la preparacion de medicamentos para el control de la produccion de estrogenos.

Country Status (25)

Country Link
US (3) US5616574A (es)
EP (6) EP1099706B1 (es)
JP (6) JP3219408B2 (es)
KR (4) KR100258396B1 (es)
AT (5) ATE194843T1 (es)
AU (2) AU689043B2 (es)
BR (1) BR9206434A (es)
CA (4) CA2305767A1 (es)
CY (4) CY2253B1 (es)
CZ (1) CZ295939B6 (es)
DE (5) DE69233149T2 (es)
DK (4) DK0921130T3 (es)
ES (4) ES2196483T3 (es)
FI (5) FI940903A7 (es)
GB (1) GB9118478D0 (es)
GE (6) GEP20022766B (es)
GR (1) GR3034579T3 (es)
HU (1) HUT66097A (es)
LV (1) LV12618B (es)
NO (6) NO307301B1 (es)
RU (4) RU2210574C2 (es)
SG (7) SG103374A1 (es)
SK (4) SK282187B6 (es)
UA (4) UA41875C2 (es)
WO (1) WO1993005064A1 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US6011024A (en) * 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9604709D0 (en) * 1996-03-05 1996-05-01 Imperial College A compound
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
WO1995026717A1 (en) * 1994-04-05 1995-10-12 Celltech Therapeutics Limited Use of estrone derivatives as steroid sulphatase inhibitors
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4447715C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Behandlung von Prostatakarzinomen
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
US6506792B1 (en) 1997-03-04 2003-01-14 Sterix Limited Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using
US6921776B1 (en) 1996-02-16 2005-07-26 Sterix Limited Compound
ATE286038T1 (de) * 1996-03-05 2005-01-15 Sterix Ltd Verbindungen mit sulfonsäure-amidgruppe
AU713341B2 (en) * 1996-09-12 1999-12-02 Teikoku Hormone Mfg. Co., Ltd. 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
US6642220B1 (en) 1996-12-05 2003-11-04 Sterix Limited Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
DE19712488A1 (de) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
GB9708716D0 (en) * 1997-04-29 1997-06-18 Imperial College Chronic heart failure
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
AU765386B2 (en) * 1998-06-10 2003-09-18 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-(o)-sulphamate for inhibition of estrone sulphatase
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
WO2000053620A1 (en) * 1999-03-10 2000-09-14 Nippon Organon K. K. Novel estradiol derivatives
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
AU2005225148B2 (en) * 1999-04-30 2008-04-03 Sterix Limited Use
JP5042411B2 (ja) * 1999-04-30 2012-10-03 ステリックス リミテッド 抗腫瘍剤としてのエストロン誘導体の使用
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
DK1237902T3 (da) * 1999-12-13 2006-03-06 Sterix Ltd Halogenerede sulphamat-, fosfonat-, thiofosfonat-, sulfonat- og sulfonamidforbindelser som hæmmere af steroid sulfatase
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
JPWO2001081364A1 (ja) * 2000-04-24 2004-01-08 協和醗酵工業株式会社 エストラ−１，３，５（１０）−トリエン誘導体
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
JP2004521951A (ja) 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
EP1657247B1 (en) * 2001-10-18 2008-09-17 Sterix Limited Steroidal compounds for inhibiting steroid sulphotase
JP4553586B2 (ja) * 2001-10-18 2010-09-29 ステリックス リミテッド ステロイドスルファターゼを阻害するための、ステロイド化合物
US20040254241A1 (en) * 2002-08-28 2004-12-16 Yoji Ino Aryl sulfamate derivatives
JPWO2004035089A1 (ja) * 2002-10-09 2006-02-09 協和醗酵工業株式会社 ホルモン依存性癌の治療剤
DE10307104A1 (de) 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DE60328233D1 (de) * 2003-05-16 2009-08-13 Theramex Sulfamatbenzothiophenderivate als steroidsulfataseinhibitoren
EP1627871B1 (en) * 2003-05-21 2010-04-14 ASKA Pharmaceutical Co., Ltd. Cyclic aminophenyl sulfamate derivative
TWI331154B (en) * 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
US20100204146A1 (en) 2007-09-17 2010-08-12 Preglem S.A. Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
EP2149371A1 (en) * 2008-07-28 2010-02-03 PregLem S.A. Use of steroid sulfatase inhibitors for the treatment of preterm labor
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
CN110974840A (zh) * 2019-12-27 2020-04-10 天津市肿瘤医院 一种类固醇硫酸酯酶抑制剂及其药物用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE114806C (es) *
DE1593846A1 (de) * 1967-01-28 1971-02-25 Hoechst Ag Verfahren zur Herstellung von Sulfamidsaeure-arylestern
US3647738A (en) * 1970-11-03 1972-03-07 Union Carbide Corp Alpha-olefin polymer compositions
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
DE2418217A1 (de) * 1974-04-13 1975-11-06 Hoechst Ag Sulfamidsaeureester und verfahren zu ihrer herstellung
DD114806A1 (es) * 1974-10-11 1975-08-20
US4340602A (en) * 1978-10-18 1982-07-20 Wayne State University Compositions inhibiting estrogen sulfotransferase activity
US4810700A (en) * 1978-10-18 1989-03-07 Wayne State University Compositions inhibiting estrogen sulfotransferase activity
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
PT94305B (pt) * 1989-06-12 1997-02-28 Robins Co Inc A H Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
ATE286038T1 (de) * 1996-03-05 2005-01-15 Sterix Ltd Verbindungen mit sulfonsäure-amidgruppe
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same

Also Published As

Publication number Publication date
CA2114630A1 (en) 1993-03-18
JP2000355542A (ja) 2000-12-26
CZ44094A3 (en) 1995-01-18
NO20025725L (no) 1994-04-29
FI940903A0 (fi) 1994-02-25
CA2114630C (en) 2003-09-30
JPH07501515A (ja) 1995-02-16
DE69233053T2 (de) 2003-11-20
JP3581802B2 (ja) 2004-10-27
NO995076L (no) 1994-04-29
KR100321018B1 (ko) 2002-03-20
FI20050991L (fi) 2005-10-03
EP0982032A2 (en) 2000-03-01
HUT66097A (en) 1994-09-28
EP0928609A2 (en) 1999-07-14
ATE278704T1 (de) 2004-10-15
KR100321019B1 (ko) 2002-03-20
DE69233431T2 (de) 2006-02-23
UA70957C2 (uk) 2004-11-15
RU2182152C2 (ru) 2002-05-10
NO314287B1 (no) 2003-03-03
RU2210574C2 (ru) 2003-08-20
SG88783A1 (en) 2002-05-21
GEP20022637B (en) 2002-02-25
CA2305758A1 (en) 1993-03-18
ATE237333T1 (de) 2003-05-15
FI20002260A7 (fi) 2000-10-13
AU717116B2 (en) 2000-03-16
GEP20022802B (en) 2002-09-25
HK1025051A1 (en) 2000-11-03
EP1099706A3 (en) 2002-09-04
ATE246706T1 (de) 2003-08-15
JP3581820B2 (ja) 2004-10-27
SG103820A1 (en) 2004-05-26
NO995076D0 (no) 1999-10-18
EP0641355B1 (en) 2000-07-19
DE69233149T2 (de) 2004-06-24
SK282187B6 (sk) 2001-12-03
FI20050991A7 (fi) 2005-10-03
DE69231280T2 (de) 2000-11-30
EP0982032A3 (en) 2002-03-20
HK1019753A1 (en) 2000-02-25
SK282189B6 (sk) 2001-12-03
JP2003176297A (ja) 2003-06-24
DK0921130T3 (da) 2003-07-21
ES2196483T3 (es) 2003-12-16
FI20002259L (fi) 2000-10-13
JP3219408B2 (ja) 2001-10-15
GEP20022766B (en) 2002-08-26
JP2000355598A (ja) 2000-12-26
RU94019334A (ru) 1996-10-20
UA70958C2 (uk) 2004-11-15
ATE239753T1 (de) 2003-05-15
AU689043B2 (en) 1998-03-19
FI940903A7 (fi) 1994-04-20
NO940635D0 (no) 1994-02-24
LV12618A (en) 2001-02-20
SG115508A1 (en) 2005-10-28
EP0921130A3 (en) 2001-09-05
NO995075D0 (no) 1999-10-18
SG73391A1 (en) 2006-08-30
NO20025725D0 (no) 2002-11-28
NO308774B1 (no) 2000-10-30
CA2305749A1 (en) 1993-03-18
AU5837396A (en) 1996-09-05
KR100322650B1 (ko) 2002-03-20
RU2207134C2 (ru) 2003-06-27
EP1099706B1 (en) 2004-10-06
JP2002255993A (ja) 2002-09-11
DE69233020D1 (de) 2003-05-22
DE69233053D1 (de) 2003-06-12
EP0928609A3 (en) 2001-11-07
SK282186B6 (sk) 2001-12-03
AU668882B2 (en) 1996-05-23
DE69231280D1 (de) 2000-08-24
LV12618B (en) 2001-07-20
US5830886A (en) 1998-11-03
NO20002595D0 (no) 2000-05-19
NO318009B1 (no) 2005-01-17
SG88782A1 (en) 2002-05-21
FI20002260L (fi) 2000-10-13
ES2193475T3 (es) 2003-11-01
NO20044458L (no) 1994-04-29
FI20002261A7 (fi) 2000-10-13
DE69233431D1 (de) 2004-11-11
DK0641355T3 (da) 2000-10-09
DE69233149D1 (de) 2003-09-11
EP0928609B1 (en) 2003-04-16
HK1020672A1 (en) 2000-05-19
NO307301B1 (no) 2000-03-13
EP0982032B1 (en) 2003-08-06
GB9118478D0 (en) 1991-10-16
EP0641355A1 (en) 1995-03-08
RU2001125673A (ru) 2003-06-27
DE69233020T2 (de) 2003-11-06
US6159960A (en) 2000-12-12
WO1993005064A1 (en) 1993-03-18
SG103374A1 (en) 2004-04-29
CY2397B1 (en) 2004-09-10
FI20002259A7 (fi) 2000-10-13
CY2253B1 (en) 2003-07-04
HU9400583D0 (en) 1994-05-30
NO308903B1 (no) 2000-11-13
EP0921130A2 (en) 1999-06-09
GEP20022803B (en) 2002-09-25
EP1099706A2 (en) 2001-05-16
JP3581821B2 (ja) 2004-10-27
BR9206434A (pt) 1994-09-27
FI20002261L (fi) 2000-10-13
EP1522543A1 (en) 2005-04-13
GR3034579T3 (en) 2001-01-31
EP0921130B1 (en) 2003-05-07
NO940635L (es) 1994-04-29
CA2305767A1 (en) 1993-03-18
SG106116A1 (en) 2004-09-30
AU2490592A (en) 1993-04-05
CY2394B1 (en) 2004-09-10
NO995075L (no) 1994-04-29
UA70956C2 (uk) 2004-11-15
CY2398B1 (en) 2004-09-10
GEP20033094B (en) 2003-10-27
CZ295939B6 (cs) 2005-12-14
ATE194843T1 (de) 2000-08-15
UA41875C2 (uk) 2001-10-15
US5616574A (en) 1997-04-01
ES2204059T3 (es) 2004-04-16
AU1007799A (en) 1999-03-04
JP2000038341A (ja) 2000-02-08
NO2595A (no) 1994-04-29
DK0928609T3 (da) 2003-07-21
KR100258396B1 (ko) 2000-08-01
SK24694A3 (en) 1994-11-09
DK0982032T3 (da) 2003-11-03
SK282188B6 (sk) 2001-12-03
GEP20063773B (en) 2006-03-27

Similar Documents

Publication Publication Date Title
ES2148178T3 (es) Uso de derivados de sulfamato como inhibidores de esteroide-sulfatasa.
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
AR005706A1 (es) Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico
ES2037752T3 (es) Utilizacion de un derivado de benzoxazol y su procedimiento de preparacion.
ES2055745T3 (es) Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
DK279790A (da) Aromatiske steroid-5-alfa-reduktaseinhibitorer
ES2063256T3 (es) Derivados avermectin cetales utiles como agentes antiparasitarios.
ES464325A1 (es) Un procedimiento para la preparacion de compuestos heteroci-clicos
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
CU23393A3 (es) Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
ES2058292T3 (es) Derivados de indol.
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
MX9300786A (es) Compuestos hipolipidaemicos.
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
AR003406A1 (es) Derivados de imidazol, procedimiento para su preparacion y preparaciones farmaceuticas que los contienen.
MX9307011A (es) Derivados hidrosolubles de camptotecina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
AR010700A1 (es) Derivados de purina sustituidos, procedimiento para su preparacion, su empleo y su agente que los contiene
AR026338A1 (es) Dihidrotiazoles policiclicos, provistos en posicion 2 de radicales alquilo sustituidos, procedimiento para su preparacion y su utilizacion comomedicamentos
MXPA04002042A (es) Compuestos de bencimidazol sustituidos y su uso para el tratamiento del cancer.
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
ES2011427T3 (es) Derivados de la oxima de octahidronaftaleno para la inhibicion de la sintesis del colesterol, procedimientos para su preparacion y composiciones que los contienen.
ES2095068T3 (es) Peroxicarbonatos polimericos y procedimiento para prepararlos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 641355

Country of ref document: ES